King Charles III was diagnosed with cancer after undergoing a procedure for an enlarged prostate, Buckingham Palace revealed on Monday. The palace did not disclose the type or severity of the cancer.
In a statement, the palace announced, “During The King’s recent hospital procedure for benign prostate enlargement, a separate issue of concern was noted. Subsequent diagnostic tests have identified a form of cancer.” However, it clarified that Charles does not have prostate cancer.
An enlarged prostate, a common condition among older men, is not typically associated with cancer. Symptoms may include difficulty urinating, loss of bladder control, or frequent nighttime urination. To address these issues, doctors often recommend a transurethral resection, a procedure to remove excess prostate tissue.
Dr. William Oh, Chief Medical Officer of the Prostate Cancer Foundation, explained that this procedure improves urination by removing tissue blocking the bladder base. A scope inserted through the urethra allows doctors to visualize and remove the tissue. Sometimes, cancer in nearby areas, like the bladder or urethra, may be detected during this process.
Dr. Christian Pavlovich, a professor at Johns Hopkins School of Medicine, noted that the scope could uncover tumors or bleeding, potentially signaling kidney or ureter cancer. However, finding cancer during a prostate enlargement procedure is rare, according to Dr. Julio Pow-Sang of Moffitt Cancer Center.
The palace did not specify the exact procedure Charles underwent. He has returned to London for outpatient cancer treatments and remains optimistic about his treatment outcome. The palace expressed gratitude to his medical team and stated that Charles looks forward to resuming full public duties soon.
